• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

退出家族性卵巢癌筛查手术的因素和对停止筛查的反应:一项定性研究。

Catalysts to withdrawal from familial ovarian cancer screening for surgery and reactions to discontinued screening: a qualitative study.

机构信息

Institute of Primary Care and Public Health, School of Medicine, Cardiff University, 2nd Floor, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK.

出版信息

Fam Cancer. 2013 Mar;12(1):19-26. doi: 10.1007/s10689-012-9567-x.

DOI:10.1007/s10689-012-9567-x
PMID:23014947
Abstract

Women at high risk of familial ovarian cancer face a potentially difficult risk management choice between unproven ovarian cancer screening (OCS) and bilateral salpingo-oophorectomy (BSO). It is not fully understood why women who initially opt for OCS may later undergo BSO, nor what the impact of this may be. This study explored the catalysts for surgery and reactions to discontinuing OCS. Semi-structured interviews were completed with 21 women who had undergone surgery having initially chosen OCS to explore their screening experiences, reasons for and feelings about surgery, and reactions to discontinuing OCS. The invasive nature and frequency of OCS were not by themselves a catalyst for surgery. A number of catalysts, including abnormal OCS test results, and secondary considerations, such as age-related factors, were found to prompt surgery. The emotional impact of discontinuing OCS following BSO varied between relief, acceptance, and loss of reassurance. OCS appears to be an acceptable risk management strategy under certain circumstances, but varying factors can prompt the decision to opt instead for BSO. The complexity of this management change decision should not be underestimated and needs to be taken into account by clinicians assisting women making choices. These findings highlight the importance of the timing of decision-making about BSO and that risk management options need routine reconsideration, through clinical discussions, information and support.

摘要

高危家族性卵巢癌女性在未经证实的卵巢癌筛查(OCS)和双侧输卵管卵巢切除术(BSO)之间面临着潜在的困难的风险管理选择。目前还不完全清楚为什么最初选择 OCS 的女性后来会选择 BSO,也不知道这会有什么影响。本研究探讨了手术的催化剂以及停止 OCS 的反应。对 21 名最初选择 OCS 进行筛查的接受过手术的女性进行了半结构式访谈,以探讨她们的筛查经历、手术的原因和感受,以及停止 OCS 的反应。OCS 的侵入性和频率本身并不是手术的催化剂。研究发现,包括 OCS 检测结果异常在内的多种催化剂,以及年龄相关因素等次要考虑因素,都会促使患者选择手术。BSO 后停止 OCS 的情绪反应因人而异,有人感到宽慰、接受,也有人感到失去了安慰。OCS 在某些情况下似乎是一种可以接受的风险管理策略,但不同的因素可能会促使患者选择 BSO。这种管理变更决策的复杂性不应被低估,临床医生在协助女性做出选择时需要考虑到这一点。这些发现强调了 BSO 决策时机的重要性,以及风险管理选择需要通过临床讨论、信息和支持进行常规重新考虑。

相似文献

1
Catalysts to withdrawal from familial ovarian cancer screening for surgery and reactions to discontinued screening: a qualitative study.退出家族性卵巢癌筛查手术的因素和对停止筛查的反应:一项定性研究。
Fam Cancer. 2013 Mar;12(1):19-26. doi: 10.1007/s10689-012-9567-x.
2
Stopping ovarian cancer screening in BRCA1/2 mutation carriers: effects on risk management decisions & outcome of risk-reducing salpingo-oophorectomy specimens.停止对携带BRCA1/2基因突变者进行卵巢癌筛查:对风险管理决策及降低风险的输卵管卵巢切除术标本结果的影响。
Maturitas. 2015 Mar;80(3):318-22. doi: 10.1016/j.maturitas.2014.12.009. Epub 2014 Dec 30.
3
An exploratory qualitative study of women's perceptions of risk management options for familial ovarian cancer: implications for informed decision making.一项关于女性对家族性卵巢癌风险管理选项认知的探索性定性研究:对知情决策的启示
Gynecol Oncol. 2004 Mar;92(3):905-13. doi: 10.1016/j.ygyno.2003.12.019.
4
A qualitative study of women's experiences of familial ovarian cancer screening.一项关于女性家族性卵巢癌筛查体验的定性研究。
Psychooncology. 2013 Nov;22(11):2576-84. doi: 10.1002/pon.3324. Epub 2013 Jun 26.
5
Using the Health Belief Model to explore why women decide for or against the removal of their ovaries to reduce their risk of developing cancer.运用健康信念模型来探究女性决定切除或不切除卵巢以降低患癌风险的原因。
BMC Womens Health. 2018 Nov 14;18(1):184. doi: 10.1186/s12905-018-0673-2.
6
Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis.影响有家族性卵巢癌风险的女性接受风险降低输卵管卵巢切除术的时间和因素:竞争风险时间事件分析。
BJOG. 2012 Apr;119(5):527-36. doi: 10.1111/j.1471-0528.2011.03257.x. Epub 2012 Jan 20.
7
Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma.高乳腺癌和卵巢癌风险女性对卵巢癌风险降低策略的满意度。
Cancer. 2011 Jun 15;117(12):2659-67. doi: 10.1002/cncr.25820. Epub 2010 Dec 29.
8
Concurrent risk-reduction surgery in patients with increased lifetime risk for breast and ovarian cancer: an analysis of the National Surgical Quality Improvement Program (NSQIP) database.同时降低乳腺癌和卵巢癌终生风险患者的风险手术:国家手术质量改进计划(NSQIP)数据库分析。
Breast Cancer Res Treat. 2018 Aug;171(1):217-223. doi: 10.1007/s10549-018-4818-7. Epub 2018 May 14.
9
Risk perception, worry, and test acceptance in average-risk women who undergo ovarian cancer screening.平均风险女性进行卵巢癌筛查的风险感知、担忧和检测接受度。
Am J Obstet Gynecol. 2014 Mar;210(3):257.e1-6. doi: 10.1016/j.ajog.2013.11.022. Epub 2013 Nov 16.
10
Prophylactic oophorectomy and ovarian cancer surveillance. Patient perceptions and satisfaction.预防性卵巢切除术与卵巢癌监测。患者的认知与满意度。
J Reprod Med. 2001 Feb;46(2):87-94.

引用本文的文献

1
Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine.使用集成手机的纸质设备检测尿液中卵巢癌生物标志物 HE4/CRE 比值,实现卵巢癌的复发监测。
Sci Rep. 2021 Nov 9;11(1):21945. doi: 10.1038/s41598-021-01544-4.
2
Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision.BRCA基因突变携带者患卵巢癌风险的建议与选择:一个复杂的决策
Cancers (Basel). 2018 Feb 21;10(2):57. doi: 10.3390/cancers10020057.
3
Decisions about prophylactic gynecologic surgery: a qualitative study of the experience of female Lynch syndrome mutation carriers.

本文引用的文献

1
Qualitative Evaluation of Medical Information Processing Needs of 60 Women Choosing Ovarian Cancer Surveillance or Prophylactic Oophorectomy.60名选择卵巢癌监测或预防性卵巢切除术的女性的医疗信息处理需求的定性评估
J Genet Couns. 2002 Apr;11(2):81-96. doi: 10.1023/A:1014571420844.
2
Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis.影响有家族性卵巢癌风险的女性接受风险降低输卵管卵巢切除术的时间和因素:竞争风险时间事件分析。
BJOG. 2012 Apr;119(5):527-36. doi: 10.1111/j.1471-0528.2011.03257.x. Epub 2012 Jan 20.
3
关于预防性妇科手术的决策:对林奇综合征女性突变携带者经历的定性研究
Hered Cancer Clin Pract. 2015 Mar 19;13(1):10. doi: 10.1186/s13053-015-0031-4. eCollection 2015.
Withdrawal from familial ovarian cancer screening for surgery: findings from a psychological evaluation study (PsyFOCS).
从家族性卵巢癌筛查中退出手术:心理评估研究(PsyFOCS)的结果。
Gynecol Oncol. 2012 Jan;124(1):158-63. doi: 10.1016/j.ygyno.2011.09.015. Epub 2011 Oct 15.
4
Illness representations and distress in women undergoing screening for familial ovarian cancer.女性进行家族性卵巢癌筛查时的疾病认知和困扰。
Psychol Health. 2011 Dec;26(12):1659-77. doi: 10.1080/08870446.2011.555544. Epub 2011 Jul 7.
5
New strategies in ovarian cancer: uptake and experience of women at high risk of ovarian cancer who are considering risk-reducing salpingo-oophorectomy.卵巢癌新策略:考虑行预防性输卵管-卵巢切除术的高风险卵巢癌女性的接受度和经验。
Clin Cancer Res. 2010 Nov 1;16(21):5094-106. doi: 10.1158/1078-0432.CCR-09-2953. Epub 2010 Sep 9.
6
Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy.女性对考虑进行风险降低性乳房切除术和风险降低卵巢切除术的“最佳时机”的建构。
BMC Womens Health. 2010 Aug 5;10:24. doi: 10.1186/1472-6874-10-24.
7
Women's decision making about risk-reducing strategies in the context of hereditary breast and ovarian cancer: a systematic review.遗传性乳腺癌和卵巢癌背景下女性关于降低风险策略的决策:一项系统综述
J Genet Couns. 2009 Dec;18(6):578-97. doi: 10.1007/s10897-009-9245-9. Epub 2009 Oct 3.
8
Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent.在乳腺癌和卵巢癌高危的未患病女性中,接受降低风险手术的情况取决于风险、年龄和时间。
Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2318-24. doi: 10.1158/1055-9965.EPI-09-0171.
9
Risk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary risk.卵巢癌的降风险手术:300 例手术的结果表明腹膜原发风险较低。
Eur J Hum Genet. 2009 Nov;17(11):1381-5. doi: 10.1038/ejhg.2009.60. Epub 2009 Apr 15.
10
Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers.对BRCA1或BRCA2基因突变携带者行降低风险的输卵管卵巢切除术相关风险降低估计值的荟萃分析。
J Natl Cancer Inst. 2009 Jan 21;101(2):80-7. doi: 10.1093/jnci/djn442. Epub 2009 Jan 13.